BerganKDV Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $35.2K | Buy |
49
+40
| +444% | +$28.7K | ﹤0.01% | 418 |
|
|
2023
Q1 | $7.4K | Hold |
9
| – | – | ﹤0.01% | 644 |
|
|
2022
Q4 | $6.49K | Hold |
9
| – | – | ﹤0.01% | 636 |
|
|
2022
Q3 | $6K | Hold |
9
| – | – | ﹤0.01% | 656 |
|
|
2022
Q2 | $5K | Hold |
9
| – | – | ﹤0.01% | 710 |
|
|
2022
Q1 | $6K | Buy |
9
+1
| +13% | +$667 | ﹤0.01% | 702 |
|
|
2021
Q4 | $5K | Hold |
8
| – | – | ﹤0.01% | 783 |
|
|
2021
Q3 | $5K | Hold |
8
| – | – | ﹤0.01% | 755 |
|
|
2021
Q2 | $4K | Hold |
8
| – | – | ﹤0.01% | 736 |
|
|
2021
Q1 | $4K | Sell |
8
-2
| -20% | -$1K | ﹤0.01% | 702 |
|
|
2020
Q4 | $5K | Buy |
10
+2
| +25% | +$1K | ﹤0.01% | 662 |
|
|
2020
Q3 | $4K | Hold |
8
| – | – | ﹤0.01% | 613 |
|
|
2020
Q2 | $5K | Buy |
8
+6
| +300% | +$3.75K | ﹤0.01% | 633 |
|
|
2020
Q1 | $1K | Sell |
2
-1,190
| -100% | -$595K | ﹤0.01% | 870 |
|
|
2019
Q4 | $448K | Sell |
1,192
-54
| -4% | -$20.3K | 0.08% | 158 |
|
|
2019
Q3 | $346K | Sell |
1,246
-407
| -25% | -$113K | 0.07% | 161 |
|
|
2019
Q2 | $517K | Sell |
1,653
-6
| -0.4% | -$1.88K | 0.1% | 135 |
|
|
2019
Q1 | $681K | Buy |
+1,659
| New | +$681K | 0.14% | 113 |
|